IBD Evidence

Dietary approach

Exclusive enteral nutrition for IBD: what the evidence shows

A period of formula-only feeding, typically six to eight weeks, with no other food.

Updated 2 min read 10 citations

What the evidence actually supports

First-line induction therapy for paediatric Crohn's disease in European guidelines, with mucosal healing rates comparable to corticosteroids and without the steroid side-effect burden. [1]

Adherence is genuinely hard and relapse on reintroduction is common. Evidence in adults is weaker than in children.

Evidence strength across the dietary approaches profiled Of the 8 dietary approaches profiled for inflammatory bowel disease, this shows how many sit at each level of evidence, with this approach graded established. Promising5 approachesEstablished1 approachesLimited1 approachesPopular but weak1 approaches
Exclusive enteral nutrition is graded established. The grades are deliberately coarse: the distance between a guideline-endorsed induction therapy and a diet with no controlled trials is the thing worth seeing, and a finer scale would imply a precision the literature does not support. Grades assigned from trial design and guideline status; see the method note.

Where it fits

This is among the better-supported dietary interventions in inflammatory bowel disease and appears in clinical guidance. That does not make it easy, and adherence is usually the limiting factor rather than efficacy.

How we grade these

Four coarse grades rather than a score. "Established" means randomised trials or guideline endorsement. "Promising" means a consistent signal from trials that are small or short. "Limited" means mechanistic or observational evidence only. "Popular but weak" means widely used and poorly supported — a category that exists because pretending those approaches are not out there helps nobody.

Other approaches

Does Exclusive enteral nutrition work for IBD?
First-line induction therapy for paediatric Crohn's disease in European guidelines, with mucosal healing rates comparable to corticosteroids and without the steroid side-effect burden. Adherence is genuinely hard and relapse on reintroduction is common. Evidence in adults is weaker than in children.
Can diet replace medication in IBD?
Generally no. Exclusive enteral nutrition is the notable exception for inducing remission in paediatric Crohn's disease. Everything else is adjunctive, and inflammation still needs monitoring.
Is a restrictive diet harmful?
It can be. Prolonged restriction reduces microbial diversity and risks nutritional gaps, which is why protocols with a reintroduction phase treat that phase as part of the intervention rather than optional.
Should I try this without telling my doctor?
No — particularly not if it might mask symptoms while inflammation continues. Symptom relief and mucosal healing are different endpoints and can diverge.

References

Every citation below links to the original peer-reviewed record on PubMed or via DOI. Nothing here is a substitute for medical advice.

  1. Using Diet to Treat Inflammatory Bowel Disease: A Systematic Review Gleave A, Shah A, Tahir U, et al. · The American journal of gastroenterology · 2025 · Systematic review DOIPubMed 39056556
  2. Risk factors for herpes zoster infections: a systematic review and meta-analysis unveiling common trends and heterogeneity patterns Steinmann M, Lampe D, Grosser J, et al. · Infection · 2024 · Meta-analysis DOIPubMed 38236326Full text
  3. AGA Clinical Practice Update on Diet and Nutritional Therapies in Patients With Inflammatory Bowel Disease: Expert Review Hashash JG, Elkins J, Lewis JD, et al. · Gastroenterology · 2024 · Clinical guideline DOIPubMed 38276922
  4. Efficacy of different dietary therapy strategies in active pediatric Crohn's disease: a systematic review and network meta-analysis Ma J, Chong J, Qiu Z, et al. · PeerJ · 2024 · Meta-analysis DOIPubMed 39686992Full text
  5. High-Fiber Diet and Crohn's Disease: Systematic Review and Meta-Analysis Serrano Fernandez V, Seldas Palomino M, Laredo-Aguilera JA, et al. · Nutrients · 2023 · Meta-analysis DOIPubMed 37513532Full text
  6. Nutrition, Nutritional Status, Micronutrients Deficiency, and Disease Course of Inflammatory Bowel Disease Valvano M, Capannolo A, Cesaro N, et al. · Nutrients · 2023 · Systematic review DOIPubMed 37686856Full text
  7. Dietary Interventions in Ulcerative Colitis: A Systematic Review of the Evidence with Meta-Analysis Herrador-López M, Martín-Masot R, Navas-López VM · Nutrients · 2023 · Meta-analysis DOIPubMed 37836478Full text
  8. Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease Sinopoulou V, Gordon M, Akobeng AK, et al. · The Cochrane database of systematic reviews · 2021 · Systematic review DOIPubMed 34844288Full text
  9. Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis Barberio B, Zamani M, Black CJ, et al. · The lancet. Gastroenterology & hepatology · 2021 · Meta-analysis DOIPubMed 33721557
  10. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD Turner D, Ricciuto A, Lewis A, et al. · Gastroenterology · 2021 · Systematic review DOIPubMed 33359090